158 related articles for article (PubMed ID: 31859463)
41. Defining the pathogenicity of creatine deficiency syndrome.
Alcaide P; Merinero B; Ruiz-Sala P; Richard E; Navarrete R; Arias A; Ribes A; Artuch R; Campistol J; Ugarte M; Rodríguez-Pombo P
Hum Mutat; 2011 Mar; 32(3):282-91. PubMed ID: 21140503
[TBL] [Abstract][Full Text] [Related]
42. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
[TBL] [Abstract][Full Text] [Related]
43. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency.
van de Kamp JM; Betsalel OT; Mercimek-Mahmutoglu S; Abulhoul L; Grünewald S; Anselm I; Azzouz H; Bratkovic D; de Brouwer A; Hamel B; Kleefstra T; Yntema H; Campistol J; Vilaseca MA; Cheillan D; D'Hooghe M; Diogo L; Garcia P; Valongo C; Fonseca M; Frints S; Wilcken B; von der Haar S; Meijers-Heijboer HE; Hofstede F; Johnson D; Kant SG; Lion-Francois L; Pitelet G; Longo N; Maat-Kievit JA; Monteiro JP; Munnich A; Muntau AC; Nassogne MC; Osaka H; Ounap K; Pinard JM; Quijano-Roy S; Poggenburg I; Poplawski N; Abdul-Rahman O; Ribes A; Arias A; Yaplito-Lee J; Schulze A; Schwartz CE; Schwenger S; Soares G; Sznajer Y; Valayannopoulos V; Van Esch H; Waltz S; Wamelink MM; Pouwels PJ; Errami A; van der Knaap MS; Jakobs C; Mancini GM; Salomons GS
J Med Genet; 2013 Jul; 50(7):463-72. PubMed ID: 23644449
[TBL] [Abstract][Full Text] [Related]
44. Female mice heterozygous for creatine transporter deficiency show moderate cognitive deficits.
Hautman ER; Kokenge AN; Udobi KC; Williams MT; Vorhees CV; Skelton MR
J Inherit Metab Dis; 2014 Jan; 37(1):63-8. PubMed ID: 23716276
[TBL] [Abstract][Full Text] [Related]
45. X-linked creatine transporter deficiency: clinical aspects and pathophysiology.
van de Kamp JM; Mancini GM; Salomons GS
J Inherit Metab Dis; 2014 Sep; 37(5):715-33. PubMed ID: 24789340
[TBL] [Abstract][Full Text] [Related]
46. Creatine deficiency syndromes: diagnostic pearls and pitfalls.
Hinnell C; Samuel M; Alkufri F; Ashkan K; Rahman Y; Turner C; Dalton RN; Nashef L
Can J Neurol Sci; 2011 Sep; 38(5):765-7. PubMed ID: 21856584
[No Abstract] [Full Text] [Related]
47. Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
Passi GR; Pandey S; Devi ARR; Konanki R; Jain AR; Bhatnagar S; Tripathi R; Jain V
Brain Dev; 2022 Apr; 44(4):271-280. PubMed ID: 34974949
[TBL] [Abstract][Full Text] [Related]
48. Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency.
Adriano E; Gulino M; Arkel M; Salis A; Damonte G; Liessi N; Millo E; Garbati P; Balestrino M
Neurosci Lett; 2018 Feb; 665():217-223. PubMed ID: 29229397
[TBL] [Abstract][Full Text] [Related]
49. Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
Wang L; Angley MT; Sorich MJ; Young RL; McKinnon RA; Gerber JP
Autism Res; 2010 Oct; 3(5):268-72. PubMed ID: 20589913
[TBL] [Abstract][Full Text] [Related]
50. A novel SLC6A8 mutation associated with intellectual disabilities in a Chinese family exhibiting creatine transporter deficiency: case report.
Wang Q; Yang J; Liu Y; Li X; Luo F; Xie J
BMC Med Genet; 2018 Nov; 19(1):193. PubMed ID: 30400883
[TBL] [Abstract][Full Text] [Related]
51. Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects.
Tokarska-Schlattner M; Epand RF; Meiler F; Zandomeneghi G; Neumann D; Widmer HR; Meier BH; Epand RM; Saks V; Wallimann T; Schlattner U
PLoS One; 2012; 7(8):e43178. PubMed ID: 22912820
[TBL] [Abstract][Full Text] [Related]
52. Urine screening for patients with developmental disabilities detected a patient with creatine transporter deficiency due to a novel missense mutation in SLC6A8.
Kato H; Miyake F; Shimbo H; Ohya M; Sugawara H; Aida N; Anzai R; Takagi M; Okuda M; Takano K; Wada T; Iai M; Yamashita S; Osaka H
Brain Dev; 2014 Aug; 36(7):630-3. PubMed ID: 24045174
[TBL] [Abstract][Full Text] [Related]
53. Early Indicators of Creatine Transporter Deficiency.
Miller JS; Thomas RP; Bennett A; Bianconi S; Bruchey A; Davis RJ; Ficicioglu C; Guthrie W; Porter FD; Thurm A
J Pediatr; 2019 Mar; 206():283-285. PubMed ID: 30579583
[TBL] [Abstract][Full Text] [Related]
54. Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome.
Valayannopoulos V; Bakouh N; Mazzuca M; Nonnenmacher L; Hubert L; Makaci FL; Chabli A; Salomons GS; Mellot-Draznieks C; Brulé E; de Lonlay P; Toulhoat H; Munnich A; Planelles G; de Keyzer Y
J Inherit Metab Dis; 2013 Jan; 36(1):103-12. PubMed ID: 22644605
[TBL] [Abstract][Full Text] [Related]
55. Detection of a novel intragenic rearrangement in the creatine transporter gene by next generation sequencing.
Yu H; van Karnebeek C; Sinclair G; Hill A; Cui H; Zhang VW; Wong LJ
Mol Genet Metab; 2013 Dec; 110(4):465-71. PubMed ID: 24140398
[TBL] [Abstract][Full Text] [Related]
56. Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.
Sharer JD; Bodamer O; Longo N; Tortorelli S; Wamelink MM; Young S
Genet Med; 2017 Feb; 19(2):256-263. PubMed ID: 28055022
[TBL] [Abstract][Full Text] [Related]
57. Creatine transporter deficiency, an underdiagnosed cause of male intellectual disability.
Jangid N; Surana P; Salmonos G; Jain V
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33334757
[TBL] [Abstract][Full Text] [Related]
58. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
[TBL] [Abstract][Full Text] [Related]
59. X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease model.
Levin MD; Bianconi S; Smith A; Cawley NX; Do AD; Hammond D; Grafstein JF; Thurm A; Miller J; Perreault J; Noguchi A; Springer D; Kozel BA; Spurney CF; Wassif CA; Yu ZX; Schulze A; Porter FD; Hannah-Shmouni F
Genet Med; 2021 Oct; 23(10):1864-1872. PubMed ID: 34050321
[TBL] [Abstract][Full Text] [Related]
60. The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation.
Puusepp H; Kall K; Salomons GS; Talvik I; Männamaa M; Rein R; Jakobs C; Õunap K
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S5-11. PubMed ID: 24137762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
